Stocks & Options
Trading Strategies
Institutional Ownership
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
PURE Bioscience, Inc. Reports Q2 2026 Financial Results
2026-03-17
SEC Filing 10-Q
(0001493152-26-010385)
Please check the link below for details.
Ticker mentioned:
PURE
Source:
Original SEC Document β